APAC IPOs & Placements, Aequitas Research

Nicholas Tan

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Aequitas ECM Weekly (26 January 2026)- Busy Ming, Montage, Eastroc, Muyuan, Longcheer, Sinotruk,

Aequitas: Muyuan Foods A/H Listing - Decent Pricing, Weak Momentum

Aequitas ECM Weekly (2 February 2026)- Eastroc, Muyuan, Han's CNC, Wuxi Lead, Sungrow, Kokusai

Aequitas: Busy Ming Pre-IPO: PHIP Update- Successful Integration and Profitability Inflection

Busy Ming Pre-IPO: Scaled up but Fragmented Market

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/busy-ming-group" target="_blank" data-smartkarma-citation="entities:45154:1" rel="noopener">Busy Ming Group (BMG HK)</a> is looking to raise up to US$430m in its upcoming Hong Kong IPO.</li>
<li>It is a rapidly growing food and beverage retailer in China. Stores are typically located in high-traffic, high visibility, and easily accessible street-side locations.</li>
<li>In this note, we examine the IPO dynamics, and look at the firm’s valuation.</li>
</ul>



Busy Ming Group (BMG HK) is looking to raise up to US$430m in its upcoming Hong Kong IPO.
It is a rapidly growing food and beverage retailer in China. Stores are typically located in high-traffic, high visibility, and easily accessible street-side locations.
In this note, we examine the IPO dynamics, and look at the firm’s valuation.


Fujian Wanchen Biotechnology Group (300972 CH)

Aequitas: Busy Ming Pre-IPO- Priced at a Discount to Peers